Top Medical News from Across Medscape

  • FDA Warning on Anaphylaxis With Rolapitant for CINVThe drug is used to prevent and reduce chemotherapy-induced nausea and vomiting (CINV) in patients with cancer; anaphylactic reactions have been seen in the postmarketing setting.
  • At-Home Cognitive Therapy Relieves IBS SymptomsSelf-administered cognitive behavioral therapy is as effective as help administered in a clinical setting to ease symptoms of irritable bowel syndrome (IBS), new research shows.
  • Tinnitus Treatment Tackles Underlying MechanismsAn intervention combining calibrated auditory and electrical pulse stimulation shows preliminary but intriguing potential to treat this often debilitating condition.
  • FDA Denies Health Claim for Vitamin D to Prevent MSThe FDA responded to a petition, saying that after reviewing the evidence, there is no basis for the claim that vitamin D can prevent multiple sclerosis in healthy people.

Special Report

Business of Medicine

  • Did Agency Knowingly Hire Dangerous Doctors?; More Agency ignored red flags in hiring physician; state bill reignites cameras-in-the-OR debate; do attorneys make better claims adjusters?
  • Are Doctors Causing Trouble by Tweeting at Conventions? Tweeting from conventions has become widespread, but some say attendees post information that should not yet be disseminated. How is Twitter affecting the presentation of scientific information?

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California